The combined therapy of Montelukast plus H1-antihistamine for for moderate to severe Japanese cedar pollinosis and its clinical efficasy
Phase 4
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-UMIN000005121
- Lead Sponsor
- Faculty of Medicine, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy, potential pregnancy, and breas-feeding patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The combined therapy of Montelukast plus H1-antihistamine
- Secondary Outcome Measures
Name Time Method itric oxide consentration in upper airway